Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Frontera London

- PMLiVE

Lundbeck’s alcohol dependency drug approved in Europe

Selincro is the first drug approved to reduce alcohol consumption

- PMLiVE

Ipsen appoints Christel Bories as deputy CEO

Has senior experience in several industries

- PMLiVE

Fitness first: How pharma can get in shape for the future

As the market changes, existing capabilities become useless and new ones become essential. Professor Brian D Smith describes how pharma companies become fit for the future

- PMLiVE

Novartis provides multimedia support to Rare Diseases Day

Collaborates with Eurordis on multimedia education campaign

ABPI London offices

ABPI to tighten up transparency compliance

Hires independent third party to monitor for incidents of non-compliance

- PMLiVE

UK study supports earlier narcolepsy finding with GSK’s Pandemrix

Flu vaccine linked to sleeping disorder

- PMLiVE

UCB CEO: Patient info more important than transparency

Roch Doliveux says misinformation is the “worst thing that can happen in healthcare”

- PMLiVE

Mylan agrees $1.6bn deal to buy Agila injectables unit

Generics firm becomes “top three player” in injectables

- PMLiVE

Former Pfizer CEO Henry McKinnell appointed CEO of Optimer

Replaces Pedro Lichtinger who is latest to leave amid compliance investigations

- PMLiVE

Hidden unmet needs in Italy’s healthcare system

Analysis reveals that regional differences persist in Italy and point towards greater use of disease data at local level to address unmet needs

- PMLiVE

NICE recommends BMS-Pfizer’s Eliquis to prevent stroke

Joins Xarelto and Pradaxa anticoagulants as potential warfarin replacement

- PMLiVE

UCB says new medicines drive growth in 2012

Also optimistic about its late-stage pipeline

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links